T&L Co., Ltd. (KOSDAQ:340570)

Market Cap	418.13B -22.2%
Revenue (ttm)	177.27B +17.9%
Net Income	43.76B +10.6%
EPS	5,421.80 +10.6%
Shares Out	8.07M
PE Ratio	9.55
Forward PE	7.88
Dividend	1,500.00 (2.90%)
Ex-Dividend Date	Dec 29, 2025

Volume	47,239
Average Volume	49,038
Open	51,500
Previous Close	52,200
Day's Range	49,600 - 52,000
52-Week Range	43,100 - 85,600
Beta	0.23
RSI	59.41
Earnings Date	Feb 4, 2026

About T&L Co., Ltd.

T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was founded in 1998 and is headquartered in Yongin-si, South Korea.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 242
• Stock Exchange: KOSDAQ
• Ticker Symbol: 340570

Financial Performance

In 2024, T&L Co., Ltd.'s revenue was 174.89 billion, an increase of 51.47% compared to the previous year's 115.46 billion. Earnings were 46.41 billion, an increase of 69.13%.